Multiple silver linings in spite of a soft Q2 24
15/05/24 -"Coloplast reported softer than expected Q2 24 figures. However, with healthy organic growth, the miss reflected FX headwinds, and, hence, was not that worrisome. Importantly, growth was strong across ..."
Pages
62
Language
English
Published on
15/05/24
You may also be interested by these reports :
11/12/25
CZM reported its full-year FY2024-25 results, aligning with guidance. Sales growth was supported by contributions from both segments, though ...
09/12/25
In addition to our estimates being revised lower, we have applied a 10% discount to peer-based valuation metrics to reflect the delayed recovery in ...
05/12/25
In addition to revising our estimates downwards to address near-term challenges, we have also injected a 20% discount into peer-based valuation ...
05/12/25
On the back of promising operating results, which also prompted management to upgrade its guidance, our estimates reset higher. This is commendable, ...